APA (7th ed.) Citation

Horne, A., Payne, A., Crawford, H., Dempsey, C., Mistry, H., Price, G., & Faivre-Finn, C. (2025). The VIGILANCE Study Protocol: An Innovative Study to Identify Prognostic and Response Biomarkers in Patients with Stage III Non-Small-Cell Lung Cancer Treated with Curative-Intent Radiotherapy. BioMed, 5(4), 27. https://doi.org/10.3390/biomed5040027

Chicago Style (17th ed.) Citation

Horne, Ashley, Amelia Payne, Harry Crawford, Clare Dempsey, Hitesh Mistry, Gareth Price, and Corinne Faivre-Finn. "The VIGILANCE Study Protocol: An Innovative Study to Identify Prognostic and Response Biomarkers in Patients with Stage III Non-Small-Cell Lung Cancer Treated with Curative-Intent Radiotherapy." BioMed 5, no. 4 (2025): 27. https://doi.org/10.3390/biomed5040027.

MLA (9th ed.) Citation

Horne, Ashley, et al. "The VIGILANCE Study Protocol: An Innovative Study to Identify Prognostic and Response Biomarkers in Patients with Stage III Non-Small-Cell Lung Cancer Treated with Curative-Intent Radiotherapy." BioMed, vol. 5, no. 4, 2025, p. 27, https://doi.org/10.3390/biomed5040027.